Parkinson'
Conditions
Interventions
mindfulness meditation program
best medical treatment
Sponsors
Wakayama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) participants diagnosed as clinically established or probable PD according to the diagnostic criteria of Movement Disorder Society, (2) QUIP-RS score was 6 or more, (3) 20 to 85 years old, (4) patients with stable dose of anti-Parkinsonian drugs and (5) who can give written informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria are participants who are currently conducting the mindfulness meditation, any other cognitive-behavioral therapy, or any other clinical trials; who have cognitive impairment (lower than 24/30 in Mini-mental state examination); and who cannot carry out the meditation program because of hearing or visual impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change of Questionnaire for Impulsive-Compulsive Disorders in PD- rating scale (QUIP-RS) score between before and after allocation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in prevalence of ICBs before and after allocation. 2. The change of following scores between before and after allocation; (1) Barratt Impulsiveness Scale 11th (BIS-11) (2) Hospital Anxiety and Depression Scale (HADS) (3) The MDS-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (4) Mindful Attention Awareness Scale (MAAS) | — |
Countries
Japan
Contacts
Public ContactJinsoo Koh
Wakayama Medical University Department of Neurology
Outcome results
None listed